30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

3Q13 Revenue: Exactech

$55.7MM, +9% (U.S. $39.1MM, +11%; ex-U.S. $16.6MM, +7%)

  • Hips $9.8MM, +6%
  • Knees $18.6MM, +2%
  • Extremities $15.1MM, +24%
  • Biologics/Spine $6.0MM, +1%
  • Other $6.1MM, +8%


  • Expecting GPS computer-assisted surgical system to be important contributor to 2014 knee growth, while Rotating Bearing Knee not expected to contribute until late 2014/early 2015
  • Ex-U.S. growth detail: up in Latin America, flat to slightly down in Europe due to economy, growing nicely in Japan